Literature DB >> 36827

Correlation of pharmacological effects with plasma levels of antihypertensive drugs in man.

Z H Israili.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 36827     DOI： 10.1146/annurev.pa.19.040179.000325

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  10 in total

Review 1.  Use of gene markers to guide antihypertensive therapy.

Authors:  S T Turner; G L Schwartz; A B Chapman; E Boerwinkle
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

2.  An LC-MS assay for the screening of cardiovascular medications in human samples.

Authors:  Eduardo Dias; Brian Hachey; Candace McNaughton; Hui Nian; Chang Yu; Brittany Straka; Nancy J Brown; Richard M Caprioli
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-08-16       Impact factor: 3.205

3.  Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension.

Authors:  G T McInnes; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Prediction of Drug Clearance from Enzyme and Transporter Kinetics.

Authors:  Priyanka R Kulkarni; Amir S Youssef; Aneesh A Argikar
Journal:  Methods Mol Biol       Date:  2021

5.  Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.

Authors:  A Wellstein; D Palm; H F Pitschner; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Acute and chronic haemodynamic effects of prazosin in left ventricular failure.

Authors:  L Stein; P R Foster; A W Friedman; J Statza; P L McHenry
Journal:  Br Heart J       Date:  1981-02

7.  Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport.

Authors:  Priyanka Kulkarni; Kenneth Korzekwa; Swati Nagar
Journal:  J Pharmacol Exp Ther       Date:  2016-07-22       Impact factor: 4.030

8.  CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.

Authors:  A L van Steveninck; M S Pieters; H C Schoemaker; D D Breimer; A F Cohen
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

Review 9.  Clinical pharmacokinetics of urapidil.

Authors:  R Kirsten; K Nelson; V W Steinijans; K Zech; R Haerlin
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

10.  Concentration-effect relationships for oxprenolol in patients with essential hypertension.

Authors:  G T McInnes; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.